Spots Global Cancer Trial Database for Quality of Life in Patients With Multiple Myeloma-validation Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Quality of Life in Patients With Multiple Myeloma-validation Study
Official Title: Validation of the Myeloma Patient Outcome Scale (MyPOS) Assessing the Quality of Life in Patients With Multiple Myeloma in the German Speaking Part of Switzerland
Study ID: NCT03537222
Conditions
Interventions
Study Description
Brief Summary: In this study, the Myeloma Patient Outcome Scale (MyPOS) will be translated from English to German. This translated version will be quantitatively and qualitatively validated with patients with multiple myeloma.
Detailed Description: Patients with multiple myeloma (N=10) will be interviewed in the qualitative phase about their comprehension of the translated MyPOS. The questionnaire will be revised according to the results of the interviews. This culturally adapted Swiss-German MyPOS will be assessed in the quantitative phase for its' psychometric properties with 200 patients with multiple myeloma.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Kantonsspital Münsterlingen, Münsterlingen, Thurgau, Switzerland
Kantonsspital Aarau, Aarau, Zurich, Switzerland
Onkozentrum Hirslanden, Zurich, , Switzerland
Contact Details
Name: Julia Dratva, Prof.Dr.med
Affiliation: Zurich University of Applied Sciences
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
